InsiderClue
← All stocks

Hanover Bancorp, Inc. /MD

HNVR Balanced
CIK 0001828588 #3965 in the set updated 17 Sep 2026
Bought (120 mo)
$1.76M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.81M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$1.81M
27 of 27 sales
Net
−$50.87K
−$50.87K against sales at will

By person

18 insiders · 80 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Golden Robert
Director
$114.00K (2)
$1.66M (25)
−$1.55M
210,856
2.99%
$5.67M
−18.2%
O'Connor Kevin M
President
$268.80K (1)
—
+$268.80K
22,300
0.3161%
$599.42K
+869.6%
Sisti Elena
Director
$261.25K (5)
—
+$261.25K
105,016
1.49%
$2.82M
+28.5%
Negrin Metin
Director
$168.00K (1)
—
+$168.00K
238,647
3.38%
$6.41M
+6.5%
PUORRO MICHAEL P
Chairman & CEO
$123.35K (5)
—
+$123.35K
321,663
4.56%
$8.65M
+27.9%
Wilcox McClelland W
President
$112.53K (3)
—
+$112.53K
97,697
1.38%
$2.63M
+79.5%
Corbett Kevin
EVP & Chief Credit Officer
$105.00K (1)
—
+$105.00K
27,936
0.3960%
$750.92K
+107.9%
Haspel Ahron H
Director
$105.00K (1)
—
+$105.00K
29,035
0.4115%
$780.46K
+109.0%
Okun Philip A
Director
$97.45K (6)
$19.95K (1)
+$77.49K
42,669
0.6048%
$1.15M
+48.0%
Burke Lance P
SEVP & Chief Financial Officer
$58.23K (6)
—
+$58.23K
27,931
0.3959%
$750.79K
+87.0%
Abraham Varkey
Director
$52.50K (1)
—
+$52.50K
45,670
0.6473%
$1.23M
+37.1%
Finneran Brian K
President
$52.50K (1)
—
+$52.50K
87,029
1.23%
$2.34M
+3.0%
Sorrenti John R
Director
$52.50K (1)
—
+$52.50K
47,209
0.6691%
$1.27M
+52.3%
Rouse Alice T
EVP & Chief Risk Officer
$42.00K (1)
—
+$42.00K
25,807
0.3658%
$693.69K
+14.8%
Diiorio Lisa A
FSVP & Chief Accounting Off.
$21.00K (1)
—
+$21.00K
17,899
0.2537%
$481.13K
+30.2%
Katz Michael David M.D.
Director
$118.92K (4)
$127.65K (1)
−$8.73K
152,267
2.16%
$4.09M
+10.5%
Vivona John P
EVP & Chief Risk Officer
$3.36K (1)
—
+$3.36K
5,152
0.0730%
$138.49K
—
Burns Joseph F
EVP & Chief Lending Officer
—
—
—
11,505
0.1631%
$309.25K
—

Individual transactions

0

Nothing of that kind in this period.

What was left out

Form 4 filings counted 148
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 27
Transactions with no price 0
Shares from compensation/vesting 554,948
History held since 11 May 2022